Interleukin-12 in Treating Patients With Multiple Myeloma

Clinical trial NCT00003149 · COMPLETED

Trial details

NCT number: NCT00003149
Sponsor: Eastern Cooperative Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma and Plasma Cell Neoplasm

Start date: 1997-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.